 BioSig Technologies, Inc. NASDAQ:BSGM has said it intends to offer shares of its common stock in a best efforts underwritten public offering. BioSig said it intends to use the net proceeds from the offering for the continuation of commercialization activities related to the PURE EP System, including additional support for organizational development, to fund working capital, and for general corporate purposes and other capital expenditures. 